<?xml version="1.0"?>

<document>
	<title>The fecal microflora and bile acids in children with cystic fibrosis.</title>

	<author>Roy-C-C.</author>
	<author>Delage-G.</author>
	<author>Fontaine-A.</author>
	<author>Robitaille-L.</author>
	<author>Chartrand-L.</author>
	<author>Weber-A.</author>
	<author>Morin-C-L.</author>

	<source>Am-J-Clin-Nutr. 1979 Dec. 32(12). P 2404-9.</source>

	<abstract>Fecal fat, bile acids, and the rectal microflora were studied in
   seven control children and in three groups of patients with cystic
   fibrosis (CF).  Seven were off antibiotics, ten on oral cloxacillin,
   and six on i.v. triple therapy (cloxacillin, gentamycin, and
   carbenicillin) for at least 2 weeks.  Controls had lower
   concentrations (milligrams per gram dry stool) of both fat (P &lt;
   0.005) and vile acids (P &lt; 0.025) than CF children off antibiotics.
   Antibiotics had little or no effect on fat but led to a striking
   decrease (P &lt; 0.01) of bile acids in the triple therapy group.
   Concomitantly, there was reduced deconjugation of bile acids (P &lt;
   0.01) and formation of secondary bile acids (P &lt; 0.005).  This was
   associated with a 5-fold increase in the percentage of bile acids
   found in the aqueous phase of stools and with a marked reduction (P
   &lt; 0.001) of the anaerobic flora (log counts per gram wet stool) in
   children on triple therapy (4.3 plus or minus 1.9) when compared to
   controls (9.8 plus or minus 0.1), CF off antibiotics (9.1 plus or
   minus 0.1) and CF on cloxacillin (9.6 plus or minus 0.2).  The close
   relationship between the anaerobic flora, the extent of bile acid
   microbial transformation, and fecal bile acid concentrations suggest
   that reduction of the anaerobic flora decreases adsorption of bile
   acids to dietary residues and microbes, favors bile acid absorption,
   and leads to a decreased fecal loss of bile acids in CF.</abstract>

	<majorsubject>ANTIBIOTICS: tu</majorsubject>
	<majorsubject>BILE-ACIDS-AND-SALTS: me</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: me, mi</majorsubject>
	<majorsubject>FECES: an, mi</majorsubject>

	<minorsubject>CARBENICILLIN: tu</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>CLOXACILLIN: tu</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: dt</minorsubject>
	<minorsubject>DRUG-THERAPY-COMBINATION</minorsubject>
	<minorsubject>GENTAMICINS: tu</minorsubject>
	<minorsubject>GRAM-NEGATIVE-AEROBIC-BACTERIA</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>INFANT</minorsubject>

	<reference>001   ROY CC                CLIN GASTROENTEROL               6   377 977</reference>
	<reference>002   ROY CC                N ENGL J MED                   297  1301 977</reference>
	<reference>003   WEBER AM              GUT                             17   295 976</reference>
	<reference>004   WEBER AM              N ENGL J MED                   289  1001 973</reference>
	<reference>005   LEFEBVRE D            EXPERIENTIA                     33   616 977</reference>
	<reference>006   HOLDEMAN LV           ANAEROBE LABORATORY MANUAL               975</reference>
	<reference>007   BEST WR               AM J CLIN NUTR                  23  1609 970</reference>
	<reference>008   JEEJEEBHOY KN         CLIN BIOCHEM                     3   157 970</reference>
	<reference>009   LEVIN SJ              ANAL CHEM                       33  1407 961</reference>
	<reference>010   WEBER AM              CLIN CHIM ACTA                  39   524 972</reference>
	<reference>011   BANCROFT TA           TOPICS IN INTERMED STAT METH     1   100 968</reference>
	<reference>012   HOLDEMAN LV           APPL ENVIRON MICROBIOL          31   539 976</reference>
	<reference>013   MOORE WEC             APPL MICROBIOL                  27   961 974</reference>
	<reference>014   ATTEBERY HR           AM J CLIN NUTR                  25  1931 972</reference>
	<reference>015   MATA LJ               AM J CLIN NUTR                  25  1380 972</reference>
	<reference>016   FLOCH MH              AM J CLIN NUTR                  25  1418 972</reference>
	<reference>017   SUTTER VL             J INFECT DIS                   131   417 975</reference>
	<reference>018   SUTTER VL             ANTIMICROB AGENTS CHEMOTHER     10   736 976</reference>
	<reference>019   MIDTVEDT T            AM J CLIN NUTR                  27  1341 974</reference>
	<reference>020   GARBUTT JT            GASTROENTEROLOGY                56   711 969</reference>
	<reference>021   KRAG E                J CLIN INVEST                   53  1686 974</reference>
	<reference>022   GUSTAFSSON BE         ACTA PATH MICROBIOL SCAND       72   433 968</reference>
	<reference>023   EASTWOOD MA           BIOCHIM BIOPHYS ACTA           152   165 968</reference>
	<reference>024   GUSTAFSSON BE         SCAND J GASTROENTEROL            3   125 968</reference>
	<reference>025   SCHIFF ER             J CLIN INVEST                   51  1351 972</reference>
	<reference>026   EASTWOOD M            AM J CLIN NUTR                  29  1461 976</reference>

	<citation>1   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    33 982</citation>
	<citation>2   BALISTRERI WF         J PEDIATR GASTROENTEROL NUTR     2   105 983</citation>
	<citation>3   ISENBERG JN           J PEDIATR GASTROENTEROL NUTR     2   447 983</citation>
	<citation>4   WESLEY A              PEDIATR RES                     17    65 983</citation>
	<citation>5   COLOMBO C             J PEDIATR GASTROENTEROL NUTR     3   556 984</citation>
	<citation>6   TAZAWA Y              J PEDIATR GASTROENTEROL NUTR     3   378 984</citation>
	<citation>7   GRYBOSKI JD           AM J GASTROENTEROL              80   871 985</citation>
	<citation>8   WEBER AM              ACTA PAEDIATR SCAND SUPPL 317 1985     9 985</citation>
	<citation>9   LEROY C               DIG DIS SCI                     31   911 986</citation>
	<citation>10   LONNQVIST B           J INFECT DIS                   153   175 986</citation>

</document>
